Research & Discovery
Curators Versus Cancer
A special team of medical literature experts are on the hunt for cancer's kryptonite, one mutation at a time.
Op-ed: Mexico Wants Internet for All. That Could Reduce Poverty
The roughly 50 million people who remain offline are also generally the country’s poorest residents, writes Jack J. Barry of UConn political science.
The Fight for Physical Literacy
Just as with reading literacy, a strong early foundation in physical literacy will have lifetime benefits, according to kinesiology professor Lindsay DiStefano.
UConn-Wesleyan Stem Cell Core: Past, Present, and Future
Established in 2006, the UConn-Wesley Stem Cell Core aims to advance stem cell research throughout the state.
Connecticut’s Marshes: Past, Present, and Uncertain Future
As the world looks increasingly to technology to sequester carbon dioxide from the atmosphere, UConn researchers are seeking to understand the natural processes involved in wetlands' ability to store carbon.
At School Lunch, Healthier Options are Overlooked When Juice is Available
Milk, fruit, and water sales decline when a less healthy option – juice – is served through the National School Lunch program, says a new UConn Rudd Center study.
UConn Startup Wins R&D Grant for Voltage-Sensitive Dyes
Potentiometric Probes, a biotech startup based on UConn Health technology, has received a grant from the National Institutes of Health (NIH) to develop a new class of voltage-sensitive dyes.
Black Students Who Have One Black Teacher Are More Likely To Go To College
The influence of having a black teacher can make a monumental difference in a black student’s life, and the effect begins early in an education, according to a new study co-authored by UConn's Joshua Hyman.
5 Takeaways on Exercise Guidelines by Age
UConn's Linda Pescatello and other top researchers nationwide authored the latest edition of the Physical Activity Guidelines for Americans, released this week.
UConn Spinout, Biorasis Receives $3M from Helmsley Charitable Trust
Invented by UConn professors, Biorasis’ technology responds to significant clinical and societal needs related to Type 1 diabetes, which affects over 30 million Americans.